Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Search
IASLC.org
IASLC Lung Cancer News
Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Home
Authors
Posts by lungcanc
lungcanc
526 POSTS
0 COMMENTS
Improved Turnaround Times for NGS Wait on Improved Technology
lungcanc
Tony S. K. Mok, BMSc, MD
lungcanc
5th AACR-IASLC International Joint Conference: Translational Progress through Basic Research
lungcanc
John V. Heymach, MD, PhD
lungcanc
Erlotinib, Crizotinib, Nivolumab: Big Three in ALCHEMIST Platform
lungcanc
Writing for Publication: Expanding the Voices of Nursing in Thoracic Oncology
lungcanc
The Lung Cancer Research Foundation and Free to Breathe Merge to...
lungcanc
Breaking News Briefs
lungcanc
Yasushi Yatabe, MD, PhD
lungcanc
Ramon Rami-Porta, MD, PhD
lungcanc
1
...
29
30
31
...
53
Page 30 of 53
Meeting News
Leora Horn, MD – IASLC Virtual Presidential Symposium Presentation
Paul Baas, MD – IASLC Virtual Presidential Symposium Presentation
TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse
cfDNA Analysis Suggests EML4-ALK Variant Does Not Influence Response to Lorlatinib
Load more
Edit with Live CSS
